ProCE Banner Activity

Reproductive Psychiatry: PMDD, Perinatal Mood Disorders, and Peri/Postmenopausal Depression Plus Comorbidities—Complex Interactions Require Comprehensive Assessment and Treatment

Slideset

Slides from the reproductive psychiatry presentation at the 9th Annual Mood Disorders Summit 2022.

Released: November 02, 2022

Expiration: November 01, 2023

No longer available for credit.
Begin Activity

Share

Faculty

Anita H. Clayton

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Provided by

Provided by Clinical Care Options, LLC

ProCE Banner

Supporters

Supported by educational grants from

Independent Educational Activity

Faculty Disclosure

Primary Author

Anita H. Clayton, MD, DLFAPA, IF

Wilford W. Spradlin Professor and Chair
Department of Psychiatry & Neurobehavioral Sciences
Professor of Clinical Obstetrics & Gynecology
University of Virginia School of Medicine
Charlottesville, Virginia

Anita Clayton, MD: researcher Dare Bioscience, Janssen, Praxis, Precision Medicines, Relmada Therapeutics, Sage Therapeutics; consultant/advisor/speaker: AbbVie, Brii Biosciences, Fabre-Kramer, Field Trip Health, Janssen Research & Development LLC, MedAvante-ProPhase, Mind Cure Health, Ovoca Bio PLC, Praxis Precision Medicines, Pure Tech Health, S1 Biopharma, Sage Therapeutics, Takeda/Lundbeck, Vella Bioscience, WCG; individual publicly traded stock and stock options: Euthymics, Mediflix LLC, S1 BioPharma.